VINC
Vincerx Pharma, Inc. Common Stock
VINC
VINC
Delisted
VINC was delisted on the 22nd of April, 2025.
22 hedge funds and large institutions have $1.26M invested in Vincerx Pharma, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 8 closing their positions.
Holders
22
Holders Change
-6
Holders Change %
-21.43%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
UBS Group
Zurich,
Switzerland
|
$24.4K |
2 |
HF
2
HRT Financial
New York
|
$15K |
3 |
![]()
3
Focus Partners Wealth
Boston,
Massachusetts
|
$2.87K |
4 |
SS
4
SBI Securities
Tokyo,
Japan
|
$263 |
5 |
5
Morgan Stanley
New York
|
$549 |